Partnership Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.5M Hold
21,162
– – 17.47% 1
2026
Q2
$25.4M Hold
21,162
– – 17.16% 1
2026
Q1
$19.5M Sell
21,162
-75
-0.4% -$76K 14.84% 2
2025
Q4
$22.8M Buy
21,237
+1
+0% +$956 16.43% 1
2025
Q3
$16.2M Sell
21,236
-528
-2% -$393K 12.48% 1
2025
Q2
$17M Sell
21,764
-63
-0.3% -$49K 13.73% 1
2025
Q1
$18M Buy
21,827
+13
+0.1% +$10.8K 15.3% 1
2024
Q4
$16.8M Buy
21,814
+40
+0.2% +$33.1K 14.02% 1
2024
Q3
$19.3M Sell
21,774
-1,376
-6% -$1.24M 13.62% 2
2024
Q2
$21M Buy
23,150
+1,450
+7% +$1.16M 15.47% 1
2024
Q1
$16.9M Hold
21,700
– – 11.84% 1
2023
Q4
$14M Buy
+21,700
New +$12.7M 10.56% 1

Other funds holding LLY

Partnership Wealth Management's LLY Position: Q3 2026 in Review

Partnership Wealth Management held its Eli Lilly (LLY) position steady in Q3 2026 at 21,162 shares worth $24.5M. The position accounts for 17.47% of the portfolio, ranked #1.

Partnership Wealth Management first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $25.4M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Partnership Wealth Management held 21,162 shares of Eli Lilly worth $24.5M as of Q3 2026.
  • Partnership Wealth Management left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 17.47% of Partnership Wealth Management's portfolio in Q3 2026, its #1 holding.
  • Partnership Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Partnership Wealth Management's Eli Lilly position peaked at $25.4M in Q2 2026.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Partnership Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.